As per the agreement, Boehringer will provide all manufacturing and product supply from preclinical through Phase 1 development. Xencor is responsible for preclinical and clinical studies and retains
The product contains 10 clinically proven ingredients such as cocoa, cinnamon, omega-3, vitamin D to lower blood sugar naturally. Along with lifestyle changes including diet and exercise Diabetes
The patent will grant OphthaliX exclusive rights for the use of drug candidate CF101 for the treatment of dry eye syndrome in the People’s Republic of China until
The ColonSentry test requires only a small blood sample and can thus be easily incorporated as a pre-screening measure into routine yearly physical exams. The assay measures the
The study reveals that C-peptide production can persist for decades after disease onset and remains functionally responsive. This suggests that patients with advanced disease, whose ß-cell function was
AR-42 is a broad-spectrum deacetylation inhibitor of both histone and non-histone proteins, which help in regulation of gene expression, cell growth and survival. The compound has shown greater
The filing represents the fifth ANDA Acella has waiting approval from the FDA, the company said. Acella develops a range of specialty pharmaceutical and other products in the
APP worked with the FDA to expedite approval of the oncology drug due to nationwide shortage, the company said. The company began the process of scheduling production so
The company will follow the advice of the EMA’s Committee for Medicinal Products for Human Use (CHMP) in making changes to the product information details for its high
In a study of overweight individuals with elevated blood glucose levels, test subjects taking GlucAffect lowered their fasting blood glucose by an average of 30%, moving to healthy
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.